[ad_1]
Mumbai, June 8 (Udaipur Kiran): Advanced Enzyme Technologies is currently trading at Rs. 370.50, up by 3.50 points or 0.95% from its previous closing of Rs. 367.00 on the BSE.
The scrip opened at Rs. 361.50 and has touched a high and low of Rs. 372.25 and Rs. 358.85 respectively. So far 3452 shares were traded on the counter.
The BSE group ‘B’ stock of face value Rs. 2 has touched a 52 week high of Rs. 419.80 on 11-May-2026 and a 52 week low of Rs. 251.90 on 30-Mar-2026.
Last one week high and low of the scrip stood at Rs. 419.80 and Rs. 352.00 respectively. The current market cap of the company is Rs. 4142.00 crore.
The promoters holding in the company stood at 43.26%, while Institutions and Non-Institutions held 30.90% and 25.84% respectively.
Advanced Enzyme Technologies has completed an additional investment of Rs 25 lakh in its wholly owned subsidiary — Advanced Nutrazyme (ANPL) by way of investing in the rights issue of 2,50,000 Equity Shares of Rs 10 each. The investment will to be utilized by ANPL for its business and/or general corporate purposes.
With this, the investment of the company in ANPL has increased to Rs 30 lakh divided into 3,00,000 Equity Shares of Rs 10 each.
Advanced Enzymes Technologies is a research driven company with global leadership in manufacturing of enzymes and probiotics. It is the largest Indian enzyme company engaged in the research and development, manufacturing and marketing of vast proprietary products developed from many indigenous enzymes & probiotics.
Bhupendra Singh Chundawat is a seasoned technology journalist with over 22 years of experience in the media industry. He specializes in covering the global technology landscape, with a deep focus on manufacturing trends and the geopolitical impact on tech companies. Currently serving as the Editor at Udaipur Kiran, his insights are shaped by decades of hands-on reporting and editorial leadership in the fast-evolving world of technology.
Related
[ad_2]
Source link